Fabiani, Emiliano
 Distribuzione geografica
Continente #
NA - Nord America 2.188
EU - Europa 2.058
AS - Asia 956
SA - Sud America 221
AF - Africa 29
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.463
Nazione #
US - Stati Uniti d'America 2.162
DE - Germania 857
CN - Cina 431
SE - Svezia 394
SG - Singapore 289
BR - Brasile 191
UA - Ucraina 168
IT - Italia 132
FR - Francia 114
PL - Polonia 110
IE - Irlanda 69
GB - Regno Unito 58
IN - India 52
FI - Finlandia 44
ID - Indonesia 43
RU - Federazione Russa 35
VN - Vietnam 34
JP - Giappone 18
BD - Bangladesh 14
TR - Turchia 14
CA - Canada 12
NL - Olanda 12
KR - Corea 11
BE - Belgio 10
AT - Austria 9
CI - Costa d'Avorio 9
ZA - Sudafrica 9
AR - Argentina 7
AU - Australia 7
CO - Colombia 7
CZ - Repubblica Ceca 7
IQ - Iraq 7
GR - Grecia 6
IR - Iran 6
LT - Lituania 6
MX - Messico 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
CL - Cile 5
ES - Italia 5
HK - Hong Kong 4
IL - Israele 4
PK - Pakistan 4
VE - Venezuela 4
BB - Barbados 3
CH - Svizzera 3
EC - Ecuador 3
EG - Egitto 3
HR - Croazia 3
JM - Giamaica 3
JO - Giordania 3
MA - Marocco 3
NO - Norvegia 3
PY - Paraguay 3
TH - Thailandia 3
AZ - Azerbaigian 2
DZ - Algeria 2
LA - Repubblica Popolare Democratica del Laos 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
BO - Bolivia 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.463
Città #
Chandler 352
Singapore 132
Jacksonville 120
Ashburn 112
Warsaw 107
Dearborn 92
Nanjing 86
Houston 83
San Mateo 79
Ann Arbor 72
Chicago 72
Beijing 67
Dublin 64
Los Angeles 60
New York 60
Wilmington 56
Woodbridge 56
Fairfield 45
Nürnberg 41
Jakarta 40
Bremen 38
Milan 36
Munich 33
Nanchang 32
Seattle 31
Lawrence 28
Buffalo 27
Redwood City 27
Moscow 26
Salt Lake City 26
Boston 25
Cattolica 21
São Paulo 21
Marseille 20
Hefei 19
Shanghai 19
Chatsworth 16
Kunming 16
Hangzhou 15
Guangzhou 14
Leawood 14
Auburn Hills 13
Changsha 13
Tampa 13
Zhengzhou 13
Frankfurt am Main 12
Shenyang 12
Cambridge 11
Elk Grove Village 11
Princeton 11
Pune 11
Hanoi 10
Izmir 10
Mountain View 10
Tianjin 10
Abidjan 9
Brussels 9
Ho Chi Minh City 9
Jiaxing 9
London 9
Rome 9
University Park 9
Augusta 8
Fremont 8
Hebei 8
Helsinki 8
Jinan 8
Washington 8
Lanzhou 7
Miami 7
Rio de Janeiro 7
Tokyo 7
Belo Horizonte 6
Boardman 6
Brooklyn 6
Edinburgh 6
Enterprise 6
Lancaster 6
Nuremberg 6
San Jose 6
Seoul 6
Atlanta 5
Barletta 5
Costa Mesa 5
Dallas 5
Las Vegas 5
Monmouth Junction 5
Norwalk 5
Paris 5
Phoenix 5
Portsmouth 5
Santa Clara 5
Simi Valley 5
Sterling 5
Athens 4
Baghdad 4
Cape Town 4
Hong Kong 4
Medellín 4
Philadelphia 4
Totale 2.742
Nome #
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 384
Fanconi anemia gene variants in therapy-related myeloid neoplasms 284
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 229
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 199
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 189
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 180
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 168
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 159
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 158
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 152
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 149
Why methylation is not a marker predictive of response to hypomethylating agents 149
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 146
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 145
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 145
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 144
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 138
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 138
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 137
Epigenetic changes in therapy-related MDS/AML 131
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 130
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 128
Similarities and differences between therapy-related and elderly acute myeloid leukemia 126
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 118
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 117
PU.1 and CEBPA expression in acute myeloid leukemia. 115
Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia 109
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 108
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 107
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 106
Clonal evolution in therapy-related neoplasms 102
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 97
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 93
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 91
Therapy-related myeloid neoplasms: Clinical perspectives 84
Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy 83
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 73
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells 62
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 57
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 34
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis 32
Totale 5.496
Categoria #
all - tutte 19.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021534 0 38 10 39 58 59 94 7 48 45 115 21
2021/2022396 45 40 5 11 31 19 5 76 17 40 51 56
2022/2023960 143 145 78 181 56 100 36 93 76 3 36 13
2023/2024380 21 96 10 15 18 95 5 15 5 7 45 48
2024/2025973 19 22 71 22 80 15 47 36 112 59 384 106
2025/2026312 299 13 0 0 0 0 0 0 0 0 0 0
Totale 5.496